In contrast, none of the subcutaneously injected melanoma cells expressing SOX10 shRNA (0 out of 16) resulted in tumor formation, even after an additional six weeks of observation.This strongly indicate that the silencing of SOX10 is highly efficacious in preventing the formation of tumors in melanoma cells in an in vivo setting (53). The gene discussed is SOX10; the disease is melanoma.